Graham, B S <br/><br/>
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network.  [electronic resource] 

 -  The Journal of infectious diseases  Mar 1993 
 - 533-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-1899 
<br/><br/><label>Standard No.: </label>10.1093/infdis/167.3.533  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--immunology<br/>Amino Acid Sequence<br/>Binding, Competitive<br/>Blotting, Western<br/>CD4-Positive T-Lymphocytes--immunology<br/>Enzyme-Linked Immunosorbent Assay<br/>Gene Products, env--biosynthesis<br/>HIV Antibodies--biosynthesis<br/>HIV Envelope Protein gp120--immunology<br/>HIV Envelope Protein gp160<br/>HIV Envelope Protein gp41--immunology<br/>HIV Infections--immunology<br/>HIV-1--immunology<br/>Humans<br/>Immunization, Secondary<br/>Molecular Sequence Data<br/>Neutralization Tests<br/>Peptide Fragments--immunology<br/>Protein Precursors--biosynthesis<br/>Recombinant Proteins--immunology<br/>Time Factors<br/>Vaccinia virus--immunology